Kabir Yousuf

kabir yousufKabir Yousuf, MD, is a Clinical Cardiologist at MedStar Chesapeake CardioVascular Associates.

Dr. Yousuf is certified in Internal Medicine, Cardiovascular Disease, and Nuclear Cardiology. His research on cardiovascular risk has been published in the Annals of Noninvasive Electrocardiology. He is a member of the American College of Cardiology, the American Society of Nuclear Cardiology, and the American Society of Echocardiography.

Dr. Yousuf received his medical degree from the Medical College of Virginia - Virginia Commonwealth University, Richmond, VA. He continued his training with an internship in Internal Medicine at the University of Tennessee in Memphis; followed by a residency in Internal Medicine at the Christiana Care Health System, Newark, DE; and a cardiovascular fellowship at Write State University, Dayton, OH.

Research Interests

Dr. Yousuf's research interests include

  • Preventive cardiology
  • Nuclear cardiology
  • Cardiovascular disease
  • Cardiac drug trialsĀ 

Selected Research

Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation (ARISTOTLE)

Dr. Yousuf was an investigator on this study, sponsored by Bristol-Myers Squibb. In this Phase 3 trial of patients with atrial fibrillation, apixaban was found to be superior to warfarin in preventing stroke.

Long-Term, Open-Label Follow-Up Treatment of Patients with Atrial Fibrillation Treated With BIBR 1048 in the PETRO Trial (PETRO Extension Trial: PETRO-Ex)

Dr. Yousuf was an investigator on this follow-up trial, sponsored by Boehringer Ingelheim Pharmaceuticals. This trial was designed to investigate the long-term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrillation, with or without chronic aspirin treatment.

View Dr. Yousuf's publications on PubMed

  • Research Areas
  • Cardiovascular